This review highlights the significant advances made in the diagno-sis and management of penile cancer. This often-aggressive tumor phenotype has been characterized by its poor prognosis, mostly attributable to its late presentation and heterogeneity of surgical care because of the paucity of cases treated at most centers. Re-cent advances in understanding of the risk factors predisposing to penile cancer, including its association with the human papilloma virus (HPV), have brought forth the socioepidemiologic concept of HPV vaccination in certain high-risk populations and countries, which remains highly debated. The management of penile cancer has evolved in recent years with the adoption of penile-sparing and minimally invasive surgical a...
Penile cancer (PeCa) is a rare malignancy with potentially devastating effects. Squamous cell carcin...
Introduction: Penile carcinoma is mostly a squamous cell carcinoma (SCC), usually originating from t...
Purpose: Penile cancer is a rare malignancy which accounts for <1% of adult male cancers. Phimosi...
Penile carcinoma is a relatively rare disease in the Western world. In this thesis it was shown that...
In 2021, approximately 122,651 people in the Netherlands were diagnosed with cancer, and one in five...
A systematic review of the current treatment options and of the outcomes of penile carcinoma has bee...
Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is bas...
Penile cancer is a disease with a high morbidity and mortality. Its prevalence is relatively rare, b...
OBJECTIVES: To analyze the current trends in local therapy approaches in patients with penile carcin...
Penile cancer is introduced in chapter 1. Chapter 2 and 3 describe immunohistochemical studies. ...
Objectives: Penile cancer is a rare malignancy with a dichotomy between its incidence and evidence g...
The majority of men who develop penile cancer are in their sixth decade of life. The most common his...
PURPOSE: Penile cancer is a rare but aggressive disease, often requiring a rapid and extensive surgi...
Penile cancer is an aggressive disease and after systemic progression it is virtually incurable. Whi...
Introduction: Carcinoma of penis is an uncommon entity. The higher incidence in developing country m...
Penile cancer (PeCa) is a rare malignancy with potentially devastating effects. Squamous cell carcin...
Introduction: Penile carcinoma is mostly a squamous cell carcinoma (SCC), usually originating from t...
Purpose: Penile cancer is a rare malignancy which accounts for <1% of adult male cancers. Phimosi...
Penile carcinoma is a relatively rare disease in the Western world. In this thesis it was shown that...
In 2021, approximately 122,651 people in the Netherlands were diagnosed with cancer, and one in five...
A systematic review of the current treatment options and of the outcomes of penile carcinoma has bee...
Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is bas...
Penile cancer is a disease with a high morbidity and mortality. Its prevalence is relatively rare, b...
OBJECTIVES: To analyze the current trends in local therapy approaches in patients with penile carcin...
Penile cancer is introduced in chapter 1. Chapter 2 and 3 describe immunohistochemical studies. ...
Objectives: Penile cancer is a rare malignancy with a dichotomy between its incidence and evidence g...
The majority of men who develop penile cancer are in their sixth decade of life. The most common his...
PURPOSE: Penile cancer is a rare but aggressive disease, often requiring a rapid and extensive surgi...
Penile cancer is an aggressive disease and after systemic progression it is virtually incurable. Whi...
Introduction: Carcinoma of penis is an uncommon entity. The higher incidence in developing country m...
Penile cancer (PeCa) is a rare malignancy with potentially devastating effects. Squamous cell carcin...
Introduction: Penile carcinoma is mostly a squamous cell carcinoma (SCC), usually originating from t...
Purpose: Penile cancer is a rare malignancy which accounts for <1% of adult male cancers. Phimosi...